StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

AXIM Biotechnologies's market cap was $901.04K on Oct 19, 2026, against $2.94M a year earlier. Over the last 5 years it ranged from $559.47K to $58.84M, with a median of $3.46M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$901.04K-71.4%
2025Dec 31, 2025$3.15M+463.2%
2024Dec 31, 2024$559.47K-87.6%
2023Dec 29, 2023$4.52M+16.8%
2022Dec 30, 2022$3.87M-93.4%
2021Dec 31, 2021$58.84M+8.5%
2020Dec 31, 2020$54.21M+136.6%
2019Dec 31, 2019$22.92M-47.9%
2018Dec 31, 2018$44.00M-91.3%
2017Dec 29, 2017$504.72M+12.7%
2016Dec 30, 2016$447.99M+3693.5%
2015Dec 31, 2015$11.81M-96.4%
2014Dec 31, 2014$330.00M–

More AXIM Biotechnologies figures

See a number that looks wrong?